The post Is American exceptionalism over or just evolving? appeared on BitcoinEthereumNews.com. American exceptionalism describes the idea that the United States (US) benefits from structural advantages – economic, financial, technological and geopolitical – that give the country a lasting lead over the rest of the world. In the markets, this has translated into decades of superior performance by US Equities, unrivalled capital depth, a pivotal US Dollar (USD) and Treasuries that are considered “risk-free”. However, as deficits widen, global trade reorganizes and US President Donald Trump drives a more protectionist agenda in his second term, one question is gaining in intensity: what if this American “premium” were to enter a phase of normalization? Where does exceptionalism come from? The American advantage rests first and foremost on vast, liquid capital markets, a predictable legal system, an entrepreneurial culture tolerant of failure and a higher education system that drives innovation. Tech giants have industrialized networks, data, and artificial intelligence (AI) on a scale unmatched by any other. The country also remains better off energetically than its developed peers, since it is a net exporter of hydrocarbons. Finally, the ability of the Treasury and Federal Reserve (Fed) to act quickly in times of stress has often reduced the duration of financial crises compared to other regions. What’s creaking today Several cracks are fuelling doubt. Deficits and debt are imposing a more costly budgetary trajectory, with interest charges now weighing on political trade-offs. Trade policy is once again becoming an offensive instrument, with tariff hikes and threats targeting allies and rivals rewriting supply chains. These measures may support domestic sectors in the short term, but they raise costs, complicate cross-border investment and pose a risk of retaliation. Added to this are more political elements. Domestic polarization and debates surrounding the independence of institutions (notably the Fed) feed a subjective risk premium. Finally, Stock market concentration, with… The post Is American exceptionalism over or just evolving? appeared on BitcoinEthereumNews.com. American exceptionalism describes the idea that the United States (US) benefits from structural advantages – economic, financial, technological and geopolitical – that give the country a lasting lead over the rest of the world. In the markets, this has translated into decades of superior performance by US Equities, unrivalled capital depth, a pivotal US Dollar (USD) and Treasuries that are considered “risk-free”. However, as deficits widen, global trade reorganizes and US President Donald Trump drives a more protectionist agenda in his second term, one question is gaining in intensity: what if this American “premium” were to enter a phase of normalization? Where does exceptionalism come from? The American advantage rests first and foremost on vast, liquid capital markets, a predictable legal system, an entrepreneurial culture tolerant of failure and a higher education system that drives innovation. Tech giants have industrialized networks, data, and artificial intelligence (AI) on a scale unmatched by any other. The country also remains better off energetically than its developed peers, since it is a net exporter of hydrocarbons. Finally, the ability of the Treasury and Federal Reserve (Fed) to act quickly in times of stress has often reduced the duration of financial crises compared to other regions. What’s creaking today Several cracks are fuelling doubt. Deficits and debt are imposing a more costly budgetary trajectory, with interest charges now weighing on political trade-offs. Trade policy is once again becoming an offensive instrument, with tariff hikes and threats targeting allies and rivals rewriting supply chains. These measures may support domestic sectors in the short term, but they raise costs, complicate cross-border investment and pose a risk of retaliation. Added to this are more political elements. Domestic polarization and debates surrounding the independence of institutions (notably the Fed) feed a subjective risk premium. Finally, Stock market concentration, with…

Is American exceptionalism over or just evolving?

American exceptionalism describes the idea that the United States (US) benefits from structural advantages – economic, financial, technological and geopolitical – that give the country a lasting lead over the rest of the world.

In the markets, this has translated into decades of superior performance by US Equities, unrivalled capital depth, a pivotal US Dollar (USD) and Treasuries that are considered “risk-free”.

However, as deficits widen, global trade reorganizes and US President Donald Trump drives a more protectionist agenda in his second term, one question is gaining in intensity: what if this American “premium” were to enter a phase of normalization?

Where does exceptionalism come from?

The American advantage rests first and foremost on vast, liquid capital markets, a predictable legal system, an entrepreneurial culture tolerant of failure and a higher education system that drives innovation.

Tech giants have industrialized networks, data, and artificial intelligence (AI) on a scale unmatched by any other.

The country also remains better off energetically than its developed peers, since it is a net exporter of hydrocarbons.

Finally, the ability of the Treasury and Federal Reserve (Fed) to act quickly in times of stress has often reduced the duration of financial crises compared to other regions.

What’s creaking today

Several cracks are fuelling doubt. Deficits and debt are imposing a more costly budgetary trajectory, with interest charges now weighing on political trade-offs.

Trade policy is once again becoming an offensive instrument, with tariff hikes and threats targeting allies and rivals rewriting supply chains.

These measures may support domestic sectors in the short term, but they raise costs, complicate cross-border investment and pose a risk of retaliation.

Added to this are more political elements. Domestic polarization and debates surrounding the independence of institutions (notably the Fed) feed a subjective risk premium.

Finally, Stock market concentration, with an outsized share of earnings and performance coming from a small techno group, makes the index more sensitive to an idiosyncratic shock.

The counter-arguments

Ending exceptionalism would require other blocs to simultaneously combine market size, rule of law, financial depth, capacity to absorb global savings, technological leadership and energy security.

However, neither Europe (financial fragmentation, demographics), nor China (capital control, governance), nor the emerging markets (institutional, size) yet tick all these boxes.

AI and advanced semiconductors are still mostly captured by the American ecosystem (venture capital, universities, cloud, solvent customers).

Even weakened by cycles, the US Dollar remains the dominant reserve currency, and the United States remains the leading global destination for private capital.

Trump, normalization or rupture?

Donald Trump’s “America First” strategy has two objectives: to re-anchor production on American soil and to renegotiate trade terms.

In the short term, this will sustain “different” growth, with more domestic capex and fewer imports.

In the medium term, effectiveness depends on the right mix. Too high, too long-lasting tariffs would undermine cost competitiveness and impoverish consumers, while “surgical” targeting could accelerate the relocation of strategic segments (energy, defense, power electronics) without breaking the investment momentum.

What the markets are watching

Three gauges could tell whether exceptionalism is rebalancing or cracking:

  • Valuation premium: As long as US earnings are growing faster and are of better quality (margins, cash flow, disciplined buybacks), a Price Earnings Ratio (P/E) premium is justified. A broadening of earnings drivers beyond the IA core would reduce concentration risk.
  • Cost of public capital: If the US 10-year and 30-year interest rates were to incorporate a “political/budgetary premium” on a lasting basis, the US assets would suffer. Conversely, a credible public finance trajectory would contain this premium.
  • The US Dollar’s international role: A cyclical downturn is not a downfall. The Greenback’s share of trade, reserves, and offshore debt remain the fundamental barometers.

Possible scenarios

  1. Benevolent normalization: US growth moderate but above G7, gradual disinflation, calibrated tariff policy. US Equities continue to outperform, with a valuation premium stable, and the US Dollar in range. American exceptionalism loses intensity, but not essence.
  2. Tariff bifurcation: More extensive tariffs lead to second-round inflation, higher financing costs, and weakening domestic non-tech margins. Relative catching-up by Europe/Asia in certain value/cyclical sectors. American exceptionalism becomes sectoral.
  3. Confidence shock: Perceived budgetary slippage, doubts about institutional independence lead to a US risk premium rising, and US Dollar volatility. Risk of multi-asset re-pricing, but US depth still attracts safe-haven flows after adjustment.

Is American exceptionalism coming to an end?

American exceptionalism probably is not going away, but it is changing shape. The United States retains the structural arsenal that built its primacy – capital, innovation, institutions – but the resulting premium will be more contested, more cyclical, and more dependent on fiscal credibility and the finesse of trade policy under Donald Trump.

For investors, the right reflex may not be to “bet against America”, but to price exceptionalism at the right price and no longer take it for granted.

Source: https://www.fxstreet.com/finance/is-american-exceptionalism-over-202509011435

Market Opportunity
OFFICIAL TRUMP Logo
OFFICIAL TRUMP Price(TRUMP)
$5.331
$5.331$5.331
-1.87%
USD
OFFICIAL TRUMP (TRUMP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23